heart failure

News

Bayer's Kerendia on course for NHS use in heart failure

Up to 280,000 people with heart failure could soon be eligible for NHS treatment with Bayer's Kerendia, following new NICE guidance.

News

Novo Nordisk microRNA drug fluffs its lines in heart failure

A microRNA-targeting drug acquired by Novo Nordisk when it bought Cardior in a $1bn-plus deal has generated disappointing results in heart failure.

News

One in four diabetics has undiagnosed heart failure; study

A study has found that undiagnosed heart failure can be detected in people with high-risk diabetes using a simple, GP-led care pathway.

News

GSK grows pipeline with 35Pharma takeover, Frontier deal

GSK CEO Luke Miels signs a pair of pipeline-expanding deals, and the first acquisition on his watch, as the group prepares for a looming patent cliff.

News

Abbott's wireless heart failure sensor cleared for NHS use

A wireless sensor the size of a paperclip, Abbott's CardioMEMS HF, can now be used routinely by the NHS to monitor patients with heart failure.

News

ESC: MSD/Bayer's Verquvo disappoints in heart failure trial

Bayer and MSD's hopes of expanding the use of Verquvo in heart failure have been dashed by a failed phase 3 trial.

Bayer's Kerendia on course for NHS use in heart failure

Novo Nordisk microRNA drug fluffs its lines in heart failure

One in four diabetics has undiagnosed heart failure; study

GSK grows pipeline with 35Pharma takeover, Frontier deal

Abbott's wireless heart failure sensor cleared for NHS use

ESC: MSD/Bayer's Verquvo disappoints in heart failure trial

UK's Mission divests kidney drug to Dimerix for $292m

Discover a new era of healthcare panel engagement: Grounded ...

heart failure

Editor's Picks